Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-577-4 | CAS number: 2186-92-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 26 Aug 1991 to 2 Oct 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study; GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
- Report date:
- 1994
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- p-(dimethoxymethyl)anisole
- EC Number:
- 218-577-4
- EC Name:
- p-(dimethoxymethyl)anisole
- Cas Number:
- 2186-92-7
- Molecular formula:
- C10H14O3
- IUPAC Name:
- 1-(dimethoxymethyl)-4-methoxybenzene
- Details on test material:
- - Name of test material (as cited in study report): Anisaldehyddimethylacetal
- Batch No.: Kol. 5160SA
- Substance No.: 90/645
- Date of production: 24 Sep 1990
- Physical state: clear slightly viscous homogenous liquid
- Storage: room temperature
- Analytical purity: 94%
- Impurities (identity and concentrations): anisic acid methylester (4 %), anisaldehyde (0 .25% )
- Purity test date: Nov. 22. 1990
- Stability under test conditions: stability of the test substance was confirmed by reanalysis.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Dr. KARL THOMAE GmbH, Biberach/Riss, FRG
- Age at study initiation: 42 days
- Weight at study initiation: mean 187 g (males), 154 g (females)
- Fasting period before study: about 16 - 20 h
- Housing: housed singly in type DK III stainless steel wire cages supplied by BECKER & Co., Castrop-Rauxel, FRG, (floor area about 800 cm2)
- Diet (e.g. ad libitum): ground Kliba maintenance diet rat/mouse/hamster, 343 meal byKlingentalmühle AG, Kaiseraugst, Switzerland; ad libitum
- Water (e.g. ad libitum): drinking water; ad libitum
- Acclimation period: at least 8 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 - 24
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12 / 12
IN-LIFE DATES: From: 03 Sept 1991 To: 2 Oct 1991
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
To prepare the solution Anisaldehyddimethylacetal was weighed depending on the dose group, then olive oil DAB 9 was added and the mixture was subsequently dissolved by shaking. The test substance preparations were made in intervals for which the stability of the test substance preparations was proven.
VEHICLE
- Concentration in vehicle: 1, 4, 20 g/100 ml
- Amount of vehicle (if gavage): 5 ml/kg bw - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Analyses regarding the characterization of the test substance were carried out prior to the start of the study. The stability of the test substance was confirmed by reanalysis. Before the beginning of the study, the evidence of stability of the test substance in the vehicle over a period of 4 hours and 4 days was ordered. Samples of each concentration obtained at the start of the study were sent to the analytical laboratory for determination of the correctness of the concentration of the test substance preparations. Due to analytical problems the reserve samples of test group 1 and 2 were also sent to the analytical laboratory.
The content of test substance preparations was determined by gas chromatography - Duration of treatment / exposure:
- 4 weeks
- Frequency of treatment:
- 21 administrations (daily, except weekends)
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 50, 200, 1000 mg/kg bw
Basis:
actual ingested
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- - Dose selection rationale: based on results of an acute oral toxicity study and a 2-week administration study, where doses of 200 and
1000 mg/kg body weight were administered to male and female Wistar rats.
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: The animals were checked for the apearance of clinical signs before and after each test substance administration. A check was made twice (Mondays to Fridays) and once a day (Saturdays, Sundays and public holidays) for general observations and moribund animals.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: Once a week an additional exact clinical examination was carried out
BODY WEIGHT: Yes
- Time schedule for examinations: once a week
FOOD CONSUMPTION:
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No
OPHTHALMOSCOPIC EXAMINATION: No
HAEMATOLOGY: Yes
- Time schedule for collection of blood: in the morning of day 24 after beginning of administration
- Anaesthetic used for blood collection: No
- Animals fasted: No
- How many animals: 5/sex/ dose group
- Parameters checked: see below
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: in the morning of day 24 after beginning of administration
- Animals fasted: No
- How many animals: 5/sex/dose group
- Parameters checked: see below
URINALYSIS: No
NEUROBEHAVIOURAL EXAMINATION: No - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
Organ weights: spleen, thymus, adrenal glands ancl testes
HISTOPATHOLOGY: Yes
Liver, Kidneys, Stomach, Spleen, Thymus, Bone marrow, Adrenal glands, Heart, Mesenteric lymphnodes, Popliteal lymphnode, Urinary bladder, AIl gross lesions - Statistics:
- Means and standard deviations were calculated for the variables food consumption, body weight and body weight change for the animals in each test group.
For clinical data a non-parametric one-way analysis of variance (KRUSKAL-WALLIS h-test) followed by a post test (MANN-WHITNEY U-test) for the hypotheses of equal medians.
For terminal body weight and of absolute and relative organ weights, a non-parametric one-way analysis of variance ( KRUSKAL-WALLIS-h test) followed by a post test (WILCOXON-Test) for the hypothesis of equal medians.
Results and discussion
Results of examinations
- Details on results:
- CLINICAL SIGNS AND MORTALITY
1000 mg/kg bw: Salivation only within 10 min after gavageing of the test substance from
the 17th application onwards.
No animal died during the course of the study .
BODY WEIGHT AND WEIGHT GAIN
1000 mg/kg bw: increased values of body weight change in males (about 9 %) and females (about 20 %)
No statistically significant differences in body weights.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
1000 mg/kg bw: increased food consumption in males and females (about 20% higher than control
values)
HAEMATOLOGY
1000 mg/kg bw: increase in polymorphonuclear neutrophils in the females (which was interpreted as signs of inflammation).
CLINICAL CHEMISTRY
1000 mg/kg bw: increase in triglycerides in both sexes
ORGAN WEIGHTS
1000 mg/kg bw: increase of absolute and relative liver weight in females
HISTOPATHOLOGY:
1000 mg/kg bw:
-hyperplasia of squamous mucosa layer of the forestomach in male and female animals
- ulcerations in the squamous mucosa layer of the forestomach in one male animal
- intracytoplasmatic vacuolation of the superficial layer of the transitional epithelium of the urinary bladder in male and female animals.
Effect levels
open allclose all
- Dose descriptor:
- NOAEL
- Effect level:
- 200 mg/kg bw/day (nominal)
- Sex:
- male/female
- Dose descriptor:
- LOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Sex:
- male/female
- Basis for effect level:
- other: irritation of the gastrointestinal tract, liver, urinary bladder
Target system / organ toxicity
- Critical effects observed:
- not specified
Any other information on results incl. tables
Salivation only within 10 min after gavageing of the test substance is most probably a local effect on the gastrointestinal tract, but not a systemic toxic effect. This is confirmed by the fact, that hyperplasia (males and females) and even ulceration (one male) was observed histopathologically in the mucosal layer of the forestomach. Also the increased food consumption (with the corresponding increase in body weight) of the animals might be a compensatory reaction on the irritation of the forestomach.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.